We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+15.44%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$1.5B
(-8.1%)
Cap. Flow
-$3.24B
Cap. Flow
% of AUM
-19.02%
Top 10 Holdings %
Top 10 Hldgs %
26.33%
Holding
2,961
New
180
Increased
949
Reduced
1,091
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coeur Mining
CDE
|
+$20.8M |
| 2 |
Atlantic Union Bankshares
AUB
|
+$16.7M |
| 3 |
Lincoln National
LNC
|
+$14.7M |
| 4 |
JBTM
JBT Marel
JBTM
|
+$13.3M |
| 5 |
Yeti Holdings
YETI
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$997M |
| 2 |
Amazon
AMZN
|
+$539M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$276M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$254M |
| 5 |
Bank of America
BAC
|
+$71.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.35% |
| 2 | Financials | 13.45% |
| 3 | Industrials | 10.46% |
| 4 | Healthcare | 10.18% |
| 5 | Communication Services | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
The RMR Group
RMR
$343M
| $136K | ﹤0.01% |
8,290
| – | – |
|
2377
ReposiTrak
TRAK
$157M
| $135K | ﹤0.01% |
6,894
| – | – |
|
|
CIO
2378
DELISTED
City Office REIT
CIO
| $134K | ﹤0.01% |
25,169
+13,605
| +118% | +$68.2K |
|
2379
John Marshall Bancorp
JMSB
$332M
| $134K | ﹤0.01% |
7,245
-169
| -2% | -$2.84K |
|
2380
Sky Harbour Group
SKYH
$378M
| $134K | ﹤0.01% |
13,741
+6,238
| +83% | +$67.4K |
|
2381
Biglari Holdings Class B
BH
$1.22B
| $134K | ﹤0.01% |
459
| – | – |
|
2382
Immersion
IMMR
$249M
| $134K | ﹤0.01% |
17,020
| – | – |
|
|
ATXS
2383
DELISTED
Astria Therapeutics
ATXS
| $134K | ﹤0.01% |
24,953
+1,604
| +7% | +$7.78K |
|
2384
Genesco
GCO
$391M
| $134K | ﹤0.01% |
6,786
| – | – |
|
|
TECX
2385
Tectonic Therapeutic
TECX
$672M
| $134K | ﹤0.01% |
+6,724
| New | +$136K |
|
|
XOMA
2386
DELISTED
Xoma
XOMA
| $134K | ﹤0.01% |
5,300
+929
| +21% | +$22.3K |
|
2387
Tredegar Corp
TG
$274M
| $133K | ﹤0.01% |
15,108
-160
| -1% | -$1.29K |
|
2388
James River Group Holdings
JRVR
$201M
| $133K | ﹤0.01% |
22,680
+16,929
| +294% | +$85.8K |
|
2389
Waterstone Financial
WSBF
$383M
| $133K | ﹤0.01% |
9,607
| – | – |
|
2390
Qorvo
QRVO
$8.67B
| $132K | ﹤0.01% |
1,551
-124
| -7% | -$8.96K |
|
2391
AXIS Capital
AXS
$7.32B
| $131K | ﹤0.01% |
1,263
-115
| -8% | -$11.4K |
|
2392
Target Hospitality
TH
$1.64B
| $131K | ﹤0.01% |
18,406
+4,179
| +29% | +$29K |
|
|
LPRO
2393
DELISTED
Open Lending Corp
LPRO
| $131K | ﹤0.01% |
67,479
+170
| +0.3% | +$275 |
|
2394
MaxCyte
MXCT
$149M
| $131K | ﹤0.01% |
60,010
+9
| +0% | +$22 |
|
|
FBLA
2395
FB Bancorp
FBLA
$253M
| $130K | ﹤0.01% |
+11,550
| New | +$128K |
|
2396
Candel Therapeutics
CADL
$836M
| $129K | ﹤0.01% |
25,546
+10,319
| +68% | +$53.1K |
|
|
ONTF
2397
DELISTED
ON24
ONTF
| $129K | ﹤0.01% |
23,752
+8,545
| +56% | +$43.8K |
|
2398
SELLAS Life Sciences
SLS
$2.5B
| $129K | ﹤0.01% |
+58,844
| New | +$90.3K |
|
2399
Safe Bulkers
SB
$781M
| $129K | ﹤0.01% |
35,665
+5,552
| +18% | +$19.9K |
|
2400
Corvus Pharmaceuticals
CRVS
$1.28B
| $128K | ﹤0.01% |
+32,091
| New | +$117K |
|
Similar funds
PCM
CS
HHII
EIM
P
BPA
NAM
MetLife Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, MetLife Investment Management held 2,961 positions worth $17B, down 8.1% from $18.5B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management withdrew a net $3.24B in Q2 2025, closing 240 positions and reducing 1,091 holdings. Its most notable exit was Apple, an estimated $997M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
Against the trend, MetLife Investment Management opened a new position in Amrize Ltd worth $2.51M.
- MetLife Investment Management's largest Q2 2025 buy was Amrize Ltd: 50,407 shares worth $2.51M.
- MetLife Investment Management added most to Coeur Mining in Q2 2025, an estimated $20.8M increase.
- MetLife Investment Management's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $276M.
- MetLife Investment Management fully exited Apple in Q2 2025, selling an estimated $997M.
- MetLife Investment Management's ten largest holdings make up 26% of its $17B portfolio in Q2 2025.
- MetLife Investment Management opened 180 new positions and closed 240 in Q2 2025.
- MetLife Investment Management's portfolio value fell 8.1% quarter-over-quarter to $17B.
Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.